Cohort50

I am part of Cohort 50 because I lost my father, far too early.

He underwent surgery twice for malignant brain tumours, yet the wider disease remained hidden. We eventually learned that he had widespread stage IV metastatic melanoma and that the tumours in his brain were part of it.

His experience became one of the reasons I started Prepaire and GenetiQ. Medicine treated what it could see, while the biological story connecting it all remained unseen. I wanted to help build a system capable of bringing those signals together sooner.

My personal focus within Cohort 50 is cancer: earlier detection, clearer diagnostics, and the development of immune-based treatments, including the CAR-NK work we are building for our next phase, that seek to fight disease while preserving the patient’s strength.